Latest News

Sibeprenlimab offers a groundbreaking treatment for immunoglobulin A nephropathy, targeting APRIL to reduce kidney damage and improve patient outcomes.

Thunderstorms significantly increase asthma-related emergency visits, highlighting the need for storm-specific preparedness and management strategies for patients.

A new FDA-approved sublingual form of cyclobenzaprine HCl shows promising efficacy and tolerability in fibromyalgia.

New vaccine developments for Crimean-Congo hemorrhagic fever offer hope for prevention, highlighting pharmacists' crucial role in future vaccination efforts.

High-dose busulfan-melphalan enhances VRd therapy, improving progression-free survival in high-risk multiple myeloma patients undergoing ASCT.

Post-pandemic, invasive pneumococcal disease cases rise among youth due to declining vaccination rates, highlighting urgent public health concerns.

Tech-Check-Tech Improves Workflow and Allows Pharmacists to Focus on Clinical Responsibilities

CAR T-cell therapy shows promise for treating HER2-positive breast cancer with CNS metastases, offering a novel approach to improve patient outcomes.

The FDA approved durvalumab with FLOT chemotherapy, revolutionizing treatment for early gastric and gastroesophageal junction cancers, enhancing survival rates.

The FDA approves a reformulated ranitidine, addressing past safety concerns while treating GERD and peptic ulcers.

With this approval, Itvisma has become the first and only gene replacement therapy available for children aged 2 years and older, teenagers, and adults with SMA.

Understanding these medications is essential for their effective use.

Explore the complexities of dietary supplement regulation, the importance of third-party testing, and how pharmacists can guide safe usage.

A more significant association with cardiovascular disease (CVD) was observed among individuals with diabetes compared with those without.

The FDA approves ruxolitinib cream for treating atopic dermatitis in children, offering hope for millions affected by this chronic skin condition.

An Illinois Court Ruling Underscores How Intent and Knowledge Factor Into False Claims Act Liability for Pharmacy Reimbursement Submissions

Discover the stages of migraines and explore innovative treatments like Symbravo, designed to alleviate pain and improve quality of life.

The combination has the potential to redefine the standard of care for a population that previously had limited therapeutic avenues.

City-level COVID-19 vaccine mandates in the US have limited impact on vaccination rates and health outcomes.

The 1-year extension period in trials will be discontinued based on the efficacy results observed in the overall study population, said Novo Nordisk.

A new study reveals fluoride in tap water enhances cognitive performance, debunking claims of its link to neurodevelopmental delays and lower IQ.